Top Markets
#1 Velas Velas +562.86%
#2 Polymath Polymath +497.25%
#3 Galxe Galxe +98.41%
#4 XION XION +69.11%
#5 Resolv wstUSR Resolv wstUSR +59.42%
#6 Cofinex Cofinex +26.88%
#7 Cysic Cysic +18.77%
#8 Unibase Unibase +15.23%
#9 Swarms Swarms +14.66%
#10 RedStone RedStone +13.72%
Coin of the day
Velas Velas
設定
言語
日本
通貨
USD
テーマ
Exscientia plc Exscientia plc

Exscientia plc

EXAI
株式のランク #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
株価
$4.84
時価総額
$633.18M
変化（1日）
3.20%
変化（1年）
0.00%
国
GB
取引 Exscientia plc (EXAI)

カテゴリー

Healthcare
Exscientia plc（EXAI）のP/B比率
April 2026 時点のP/B比率 TTM: 1.26
Exscientia plc の最新の財務報告および株価によると、現在のP/B比率（TTM）は 1.26 です。2022 年末時点でのP/B比率は 1.36 でした。
Exscientia plc の P/B 比率の履歴（2019 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 1.26 -27.40%
2023 1.74 28.33%
2022 1.36 -67.63%
2021 4.20 -85.97%
2020 29.94 -64.81%
2019 85.08 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5.2875 318.55%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.074 380.80%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.5436 101.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.5196 257.76%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5468 101.60%
AU